Literature DB >> 22328094

REM sleep behavior disorder and REM sleep without atonia as an early manifestation of degenerative neurological disease.

Stuart J McCarter1, Erik K St Louis, Bradley F Boeve.   

Abstract

Rapid eye movement (REM) sleep behavior disorder (RBD) is a parasomnia characterized by repeated episodes of dream enactment behavior and REM sleep without atonia (RSWA) during polysomnography recording. RSWA is characterized by increased phasic or tonic muscle activity seen on polysomnographic electromyogram channels. RSWA is a requisite diagnostic feature of RBD, but may also be seen in patients without clinical symptoms or signs of dream enactment as an incidental finding in neurologically normal individuals, especially in patients receiving antidepressant therapy. RBD may be idiopathic or symptomatic. Patients with idiopathic RBD often later develop other neurological features including parkinsonism, orthostatic hypotension, anosmia, or cognitive impairment. RSWA without clinical symptoms as well as clinically overt RBD also often occurs concomitantly with the α-synucleinopathy family of neurodegenerative disorders, which includes idiopathic Parkinson disease, Lewy body dementia, and multiple system atrophy. This review article considers the epidemiology of RBD, clinical and polysomnographic diagnostic standards for both RBD and RSWA, previously reported associations of RSWA and RBD with neurodegenerative disorders and other potential causes, the pathophysiology of which brain structures and networks mediate dysregulation of REM sleep muscle atonia, and considerations for the effective and safe management of RBD.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22328094      PMCID: PMC3656587          DOI: 10.1007/s11910-012-0253-z

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN: 1528-4042            Impact factor:   5.081


  91 in total

1.  Predicting the future in idiopathic rapid-eye movement sleep behaviour disorder.

Authors:  Bradley F Boeve
Journal:  Lancet Neurol       Date:  2010-09-24       Impact factor: 44.182

2.  Rapid-eye-movement sleep behaviour disorder as an early marker for a neurodegenerative disorder: a descriptive study.

Authors:  Alex Iranzo; José Luis Molinuevo; Joan Santamaría; Mónica Serradell; María José Martí; Francesc Valldeoriola; Eduard Tolosa
Journal:  Lancet Neurol       Date:  2006-07       Impact factor: 44.182

3.  REM sleep behavior disorder initiated by acute brainstem multiple sclerosis.

Authors:  Maja Tippmann-Peikert; Bradley F Boeve; B Mark Keegan
Journal:  Neurology       Date:  2006-04-25       Impact factor: 9.910

4.  Use of pramipexole in REM sleep behavior disorder: results from a case series.

Authors:  Markus H Schmidt; Vipin B Koshal; Helmut S Schmidt
Journal:  Sleep Med       Date:  2006-07-03       Impact factor: 3.492

5.  A putative flip-flop switch for control of REM sleep.

Authors:  Jun Lu; David Sherman; Marshall Devor; Clifford B Saper
Journal:  Nature       Date:  2006-05-10       Impact factor: 49.962

6.  Update on the pharmacology of REM sleep behavior disorder.

Authors:  Jean-François Gagnon; Ronald B Postuma; Jacques Montplaisir
Journal:  Neurology       Date:  2006-09-12       Impact factor: 9.910

7.  Neuropsychological differentiation of dementia with Lewy bodies from normal aging and Alzheimer's disease.

Authors:  Tanis J Ferman; Glenn E Smith; Bradley F Boeve; Neill R Graff-Radford; John A Lucas; David S Knopman; Ronald C Petersen; Robert J Ivnik; Zbigniew Wszolek; Ryan Uitti; Dennis W Dickson
Journal:  Clin Neuropsychol       Date:  2006-12       Impact factor: 3.535

8.  A two-part, double-blind, placebo-controlled trial of exogenous melatonin in REM sleep behaviour disorder.

Authors:  Dieter Kunz; Richard Mahlberg
Journal:  J Sleep Res       Date:  2010-12       Impact factor: 3.981

9.  Decreased striatal dopamine transporter uptake and substantia nigra hyperechogenicity as risk markers of synucleinopathy in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study [corrected].

Authors:  Alex Iranzo; Francisco Lomeña; Heike Stockner; Francesc Valldeoriola; Isabel Vilaseca; Manel Salamero; Jose Luis Molinuevo; Monica Serradell; Joan Duch; Javier Pavía; Judith Gallego; Klaus Seppi; Birgit Högl; Eduard Tolosa; Werner Poewe; Joan Santamaria
Journal:  Lancet Neurol       Date:  2010-09-16       Impact factor: 44.182

10.  Olfactory deficit in idiopathic rapid eye movements sleep behavior disorder.

Authors:  Maria Livia Fantini; Ronald B Postuma; Jacques Montplaisir; Luigi Ferini-Strambi
Journal:  Brain Res Bull       Date:  2006-08-07       Impact factor: 4.077

View more
  40 in total

1.  A 76 Year-Old Woman with Sleep and Waking Stridor, Sleep Talking, Orthostatic Hypotension, and Imbalance.

Authors:  Erik K St Louis; Ethan J Duwell; Diana M Orbelo; Eduardo E Benarroch; Elizabeth A Coon; Bradley F Boeve; Michael H Silber
Journal:  J Clin Sleep Med       Date:  2016-01       Impact factor: 4.062

Review 2.  Young-onset dementia.

Authors:  Dulanji K Kuruppu; Brandy R Matthews
Journal:  Semin Neurol       Date:  2013-11-14       Impact factor: 3.420

3.  REM sleep muscle activity in idiopathic REM sleep behavior disorder predicts phenoconversion.

Authors:  Stuart J McCarter; David J Sandness; Allison R McCarter; John C Feemster; Luke N Teigen; Paul C Timm; Bradley F Boeve; Michael H Silber; Erik K St Louis
Journal:  Neurology       Date:  2019-08-16       Impact factor: 9.910

Review 4.  Melatonin therapy for REM sleep behavior disorder: a critical review of evidence.

Authors:  Ian R McGrane; Jonathan G Leung; Erik K St Louis; Bradley F Boeve
Journal:  Sleep Med       Date:  2014-10-13       Impact factor: 3.492

5.  Diagnostic REM sleep muscle activity thresholds in patients with idiopathic REM sleep behavior disorder with and without obstructive sleep apnea.

Authors:  Stuart J McCarter; Erik K St Louis; David J Sandness; Ethan J Duwell; Paul C Timm; Bradley F Boeve; Michael H Silber
Journal:  Sleep Med       Date:  2016-05-11       Impact factor: 3.492

6.  Psychosocial risk factors, pre-motor symptoms and first-time hospitalization with Parkinson's disease: a prospective cohort study.

Authors:  A J Clark; B Ritz; E Prescott; N H Rod
Journal:  Eur J Neurol       Date:  2013-02-23       Impact factor: 6.089

Review 7.  Idiopathic REM sleep behaviour disorder in the development of Parkinson's disease.

Authors:  Bradley F Boeve
Journal:  Lancet Neurol       Date:  2013-04-09       Impact factor: 44.182

Review 8.  Sleep Disturbances in Frontotemporal Dementia.

Authors:  Stuart J McCarter; Erik K St Louis; Bradley F Boeve
Journal:  Curr Neurol Neurosci Rep       Date:  2016-09       Impact factor: 5.081

Review 9.  Treatment of REM Sleep Behavior Disorder.

Authors:  Youngsin Jung; Erik K St Louis
Journal:  Curr Treat Options Neurol       Date:  2016-11       Impact factor: 3.598

10.  Sleep dysfunction in multiple system atrophy.

Authors:  Luigi Ferini-Strambi; Sara Marelli
Journal:  Curr Treat Options Neurol       Date:  2012-10       Impact factor: 3.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.